Navigation Links
Cancer Patients in North Wales to Gain Access to Varian's RapidArc Radiotherapy Treatments
Date:5/7/2009

RHYL, North Wales, May 7 /PRNewswire-FirstCall/ -- Glan Clywd Hospital will soon offer local cancer patients across North Wales more advanced radiotherapy treatments using RapidArc(TM) radiotherapy technology on two new treatment machines from Varian Medical Systems (NYSE: VAR). When the Clinac(R) linear accelerators with RapidArc are installed, the hospital is set to become the first in Wales to offer this new, faster form of radiotherapy that extends more advanced care to more patients.

The new machines ordered in March will be installed in new treatment rooms to be constructed at the hospital beginning in June. The project is part of a multi-million pound initiative to replace ageing machines in the hospital, which serves a population of more than 700,000 across North Wales. The new equipment should be clinical by early 2011.

Equipped with On-Board Imager(R) devices for advanced X-ray imaging and RapidArc capability, the new machines will be used to deliver image-guided IMRT (intensity modulated radiotherapy) up to eight times more quickly than with conventional IMRT. Faster treatments have significant benefits in terms of precision, since the patient has less time to move during a treatment session, and patient comfort, as the patient is on the couch for less time.

"This is a big step forward because our current treatment machines have been used continuously since we opened ten years ago and they do not allow us to perform the most modern and advanced treatments," says Dr. Jaap Vaarkamp, head of radiotherapy physics at Glan Clwyd Hospital. "RapidArc is very exciting because it makes IMRT much quicker to deliver. We are currently only able to use IMRT on one of our machines, so this is a major step forward."

Nest Bowl, radiotherapy services manager, said the investment project was given the go-ahead by the Welsh Assembly in April 2009 as part of a ten-year strategy to upgrade radiotherapy provision in Wales. She said Varian equipment was selected after a rigorous tender process. "We are very excited about being able to offer our patients image-guided and RapidArc treatments," she added. "We already use Varian equipment so it also makes sense from an interface and training perspective to acquire the latest Varian technology."

With RapidArc, Varian's Clinac accelerator can target beams at a tumor while continuously rotating around the patient, delivering a precise and efficient treatment in single or multiple arcs. Conventional IMRT treatments are slower and more difficult for radiotherapy radiographers because they target tumors using a complex sequence of fixed beams from multiple angles.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 79 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genes Linked to Spread of Breast Cancer
2. New universal breast cancer marker predicts recurrence and clinical outcome
3. Novel gene predicts local recurrence in early onset breast cancer
4. Transatlantic alliance supports breast cancer research
5. Video: Research in Womens Cancers Leading the Personalized Medicine Revolution
6. American Cancer Society Awarded Dual WellPoint Foundation Grants to Expand Hope Lodge Network and Patient Navigation Program
7. Chinese Non-Small-Cell Lung Cancer Drug Market Will More Than Double by 2013
8. South Carolina Dermatologists Win Tennis Fans Attention With Free Skin Cancer Checks and Sun Safety Tips
9. Banner Health, M. D. Anderson Announce Cancer Care Facility for Arizona
10. Go Pink on Mothers Day to Fight Breast Cancer
11. Novel gene predicts local recurrence in early-onset breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Mt. Angel Vitamins, ... a months-long rebranding effort. This includes the introduction of new packaging and messaging, ... market research, we learned that a simple, proactive approach to wellness is important ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 ... alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To ... 1512, which proposes a tax on prescription opioids to fund drug rehabilitation and ...
(Date:3/26/2017)... , ... March 26, 2017 , ... ... to receive the RealSelf 100 Award, a prestigious award honoring the top influencers ... and to find and connect with doctors and clinics. , In 2016, more ...
(Date:3/24/2017)... ... 2017 , ... Clean Earth, Inc., a leader in providing ... materials announced today the acquisition of privately owned AERC Recycling Solutions ... facilities and a vast array of additional technologies, services, and new markets to ...
(Date:3/24/2017)... NY (PRWEB) , ... March 24, 2017 , ... ... scale; from third world countries to hospitals in the United States, it’s a ... conversation on the current obstacles facing infection prevention and offers strategies for the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017  Sanderling Ventures, portfolio company, Torax ... division of Johnson & Johnson. Torax manufactures and markets ... of gastro-esophageal reflux disease (GERD). The LINK device ... and the procedure is currently available in the ... Medical was founded by Sanderling Ventures, Mayo Medical ...
(Date:3/27/2017)... 27, 2017 BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today that AGI-134, an immunotherapy for the treatment of multiple ... will be featured at the upcoming American Association for ... DC to be held on April 1-5, 2017. ... An ...
(Date:3/27/2017)... 2017 The global clinical ... billion by 2025, according to a new study by ... diseases is anticipated to be responsible for the high ... the scope for growth during the forecast period. In ... is highly susceptible to chronic diseases, is presumed to ...
Breaking Medicine Technology: